Biotech Direct: MassBio CEO Kendalle Burlin O'Connell and Seaport Therapeutics Founder & CEO Daphne Zohar discuss NIH funding, recent developments at FDA, and improving the public's view of science
- Aug 15, 2025
- 1 min read
In this inaugural episode of Biotech Direct, BiotechTV's new show that will share the biotech industry's perspective on policy and regulatory news, Kendalle Burlin O'Connell and Daphne Zohar discuss the strategic importance of biotech to the United States, share their thoughts on new FDA initiatives, and brainstorm ways to raise public awareness of the importance of science.
Chapters:
(2:44) – Biotech’s strategic importance
(4:06) – Funding cuts
(10:10) – New policy ideas
(12:50) – Vinay Prasad news
(16:59) – Making CRLs public
(21:25) – Commissioner’s National Priority Voucher
(23:31) – Improving the public’s perception of science
.png){kind=logo}